2-chloromandelic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 97720 |
| CHEMBL ID | 1253488 |
| SCHEMBL ID | 24733 |
| MeSH ID | M0536580 |
| Synonym |
|---|
| nsc31401 |
| 10421-85-9 |
| nsc-31401 |
| IDI1_016268 |
| SR-01000640397-1 |
| 2-chloromandelic acid, 98% |
| MAYBRIDGE3_004881 |
| (2-chlorophenyl)glycolic acid |
| AC-11515 |
| HMS1444N19 |
| 2-(2-chlorophenyl)-2-hydroxyacetic acid |
| dl-2-chloromandelic acid |
| AKOS005265536 |
| 2-chloromandelic acid |
| CHEMBL1253488 |
| A829322 |
| 2-(2-chlorophenyl)-2-oxidanyl-ethanoic acid |
| einecs 233-900-9 |
| ai3-07572 |
| nsc 31401 |
| benzeneacetic acid, 2-chloro-alpha-hydroxy- |
| CCG-51073 |
| FT-0601071 |
| FT-0604456 |
| FT-0601070 |
| AM20060483 |
| 2-chloro-mandelic acid |
| RWOLDZZTBNYTMS-UHFFFAOYSA-N |
| racemic 2-hydroxy-2-(2-chlorophenyl)acetic acid |
| (2-chlorophenyl)hydroxyacetic acid |
| SCHEMBL24733 |
| SY008253 |
| SY008252 |
| FS-2456 |
| W-108819 |
| mfcd00084962 |
| CS-W002349 |
| F8882-4325 |
| SY004557 |
| (r,s)-2-chloromandelic acid |
| s-2-chloromandelic acid |
| SB44338 |
| DTXSID101314879 |
| EN300-192864 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID515780 | Intrinsic solubility of the compound in water | 2010 | Bioorganic & medicinal chemistry, Oct-01, Volume: 18, Issue:19 | QSAR-based solubility model for drug-like compounds. |
| AID1130306 | Inhibition of glycolic acid oxidase (unknown origin) assessed as enzyme-mediated reduction of NaDCIP by sodium glycolate after 1 to 3 mins by spectrophotometer analysis | 1979 | Journal of medicinal chemistry, Jun, Volume: 22, Issue:6 | Quantitative structure-activity relationships involving the inhibition of glycolic acid oxidase by derivatives of glycolic and glyoxylic acids. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 12 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 14 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|